High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels
Historically high-density lipoproteins (HDL) have been viewed as antiatherogenic and beneficial. This conclusion was based on early prospective longitudinal cohorts and the broad functionality of these lipoproteins which include reverse cholesterol transport as well as activities that antagonize oxi...
Saved in:
Main Authors: | Beata Franczyk, Ewelina Młynarska, Magdalena Rysz-Górzyńska, Anna Gluba-Sagr, Jacek Rysz, Sohum Sheth, Stanislaw Surma, Maciej Banach, Peter P. Toth |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-09-01
|
Series: | American Journal of Preventive Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667725001436 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology
by: N. N. Smirnova, et al.
Published: (2023-12-01) -
PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2017-07-01) -
Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01) -
The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01) -
LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)